Works matching IS 08909091 AND DT 2010 AND VI 24 AND IP 5
Results: 18
Integrative oncology. Complementary therapies, herbs, and other OTC agents. Selenium.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The Abbas/Yang/Fakih article reviewed. Chemoradiation for anal cancer: the more things change, the more they stay the same.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The Abbas/Yang/Fakih article reviewed. Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canal.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The Murphy/Fornier article reviewed. Targeting alternative pathways in HER2-positive breast cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Management of anal cancer in 2010: part 2: current treatment standards and future decisions.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
HER2-positive breast cancer: beyond trastuzumab.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The Oxnard/Miller article reviewed. EGFR TKIs for advanced NSCLC: practical questions.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The Oxnard/Miller article reviewed. Personalized medicine for non-small--cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Use of erlotinib or gefitinib as initial therapy in advanced NSCLC.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
INTEGRATIVE ONCOLOGY.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 432
- Publication type:
- Article
Chemoradiation for Anal Cancer: The More Things Change, the More They Stay the Same.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 427
- By:
- Publication type:
- Article
Optimizing Outcomes of Chemoradiation in the Management of Squamous Cell Carcinoma of the Anal Canal.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 424
- By:
- Publication type:
- Article
Management of Anal Cancer in 2010.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 417
- By:
- Publication type:
- Article
Targeting Alternative Pathways in HER2-Positive Breast Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 415
- By:
- Publication type:
- Article
HER2-Positive Breast Cancer: Beyond Trastuzumab.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 410
- By:
- Publication type:
- Article
EGFR TKIs for Advanced NSCLC: Practical Questions.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 400
- By:
- Publication type:
- Article
Personalized Medicine for Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 399
- By:
- Publication type:
- Article
Use of Erlotinib or Gefitinib as Initial Therapy in Advanced NSCL.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 5, p. 392
- By:
- Publication type:
- Article